How is CTLA-4 blocked?

A protein found on T cells (a type of immune cell) that helps keep the body’s immune responses in check. When CTLA-4 is bound to another protein called B7, it helps keep T cells from killing other cells, including cancer cells. Some anticancer drugs, called immune checkpoint inhibitors, are used to block CTLA-4.

What is immune blockade?

A type of drug that blocks proteins called checkpoints that are made by some types of immune system cells, such as T cells, and some cancer cells. These checkpoints help keep immune responses from being too strong and sometimes can keep T cells from killing cancer cells.

What are Treg cells?

Regulatory T cells (Tregs) are a specialized subpopulation of T cells that act to suppress immune response, thereby maintaining homeostasis and self-tolerance. It has been shown that Tregs are able to inhibit T cell proliferation and cytokine production and play a critical role in preventing autoimmunity.

What is CTLA-4 antibody?

Cytotoxic T lymphocyte-associated antigen (CTLA-4), also known as CD152, is a co-inhibitory molecule that functions to regulate T cell activation. Antibodies that block the interaction of CTLA-4 with its ligands B7. 1 and B7. 2 can enhance immune responses, including anti-tumor immunity.

What does CTLA-4 stand for?

The cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1) immune checkpoints are negative regulators of T-cell immune function.

What is PD-1 blockade?

PD-1/PD-L1 blockade is a breakthrough in cancer immunotherapy, and it has been trialed in a broad range of malignancies in the preclinical or clinical stage, including melanoma [6], Hodgkin’s lymphoma [7], breast cancer [8, 9], non-small cell lung cancer (NSCLC) [10], as well as hepatocellular carcinoma [11, 12].

What are the types of immunotherapy?

Types of Immunotherapy

• Immune Checkpoint Inhibitors.
• Adoptive Cell Therapies.
• Monoclonal Antibodies.
• Oncolytic Virus Therapy.
• Cancer Vaccines.
• Immune System Modulators.

How do Treg cells work?

As the name suggests regulatory T cells (also called Tregs) are T cells which have a role in regulating or suppressing other cells in the immune system. Tregs control the immune response to self and foreign particles (antigens) and help prevent autoimmune disease. Tregs produced by a normal thymus are termed ‘natural’.

What is checkpoint blockade immunotherapy?

Checkpoint blockade immunotherapy is an innovative treatment that uses medications known as immune checkpoint inhibitors to address several types of cancer.

What is an example of an immune checkpoint inhibitor?

Examples of checkpoint inhibitors include pembrolizumab (Keytruda), ipilimumab (Yervoy), nivolumab (Opdivo) and atezolizumab (Tecentriq).

What is the process used in immunotherapy to block the CTLA-4 molecule?

Ipilimumab (Yervoy) is a monoclonal antibody that attaches to CTLA-4 and stops it from working. This can help boost the body’s immune response against cancer cells. This drug is typically used along with a PD-1 inhibitor, such as nivolumab. It can be used to treat melanoma of the skin and several other types of cancer.

What drugs are CTLA-4 inhibitors?

CTLA-4 is a protein that plays an important role in the immune system. It helps keep the immune system in check by regulating T cells. Ipilimumab (Yervoy) and tremelimumab are two immune checkpoint inhibitor drugs that block CTLA-4 to allow T cells to find and fight cancers such as mesothelioma.

What is the best immunotherapy drug?

Pembrolizumab (Keytruda), a PD-1 inhibitor manufactured by Merck & Co., holds a strong lead among top immunotherapy drugs on the market. Keytruda treats melanoma, classic Hodgkin lymphoma, and metastatic non-small cell lung cancer, among other cancers. Keytruda alone generated $11.1 billion in sales for Merck in 2019.

How do Treg cells regulate immune response?

Conventional Th cells control the adaptive immunity by activating, in an antigen-specific fashion, other effector cells such as CD8+ cytotoxic T cells, B cells and macrophages. Treg cells are defined as T cells in charge of suppressing potentially deleterious activities of Th cells.

Are there any clinical trials of the B7-H4 blocking antibody?

To date, clinical trials utilizing an anti-human B7-H4 blocking antibody have not been conducted in any disease indication.

What is the function of B7 H4?

The coinhibitory molecule B7-H4, an important member of the B7 family, is abnormally expressed in tumors, inflammation and autoimmune diseases. B7-H4 negatively regulates T cell immune response and promotes immune escape by inhibiting the proliferation, cytokine secretion, and cell cycle of T cells. …

What do we know about anti-mouse B7-H4 antibodies?

Another anti-mouse B7-H4 antibody (3E8) showed reversal of B7-H4-mediated decreases in cytokine secretion post-murine T-cell activation [22]. Additionally, anti-mouse B7-H4 antibodies are able to augment T-cell responses in vivo [11,13] and decrease tumor burden in a syngeneic B7-H4-expressing murine lung cancer model [49].

Does B7-H4 inhibit T cell function?

B7-H4 function B7-H4 inhibits T-cell function A growing body of literature suggests that B7-H4 on the cell surface binds the putative B7-H4 receptor on activated CD4+and CD8+T cells resulting in the inhibition of effector function via cell cycle arrest, decreased proliferation, and reduced IL-2 production.